Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000461673 | SCV000721860 | likely benign | not provided | 2019-10-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313219 | SCV000739412 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-03-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV002063680 | SCV002449013 | likely benign | Adams-Oliver syndrome 5 | 2023-10-27 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002063680 | SCV002555127 | likely benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270538 | SCV002555128 | likely benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000461673 | SCV001807341 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000461673 | SCV001967144 | likely benign | not provided | no assertion criteria provided | clinical testing |